These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 3266768

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [A double blind study of the evaluation of the optimal dose and its frequency in oral administration of OK-432 (Picibanil) by immunological parameters (the 1st report)].
    Shiraishi T, Nio Y, Imai S, Tsubono M, Morimoto H, Tseng CC, Tobe T, Tanaka T, Kitamura O, Sakanashi S.
    Nihon Gan Chiryo Gakkai Shi; 1990 Apr 20; 25(4):799-811. PubMed ID: 2196311
    [Abstract] [Full Text] [Related]

  • 4. [A case of advanced gastric cancer responsive to intratumoral OK-432 injection].
    Sakai Y, Maeda M, Koyama W, Totsuka S, Sakamoto S, Kanayama M.
    Gan To Kagaku Ryoho; 1988 Jun 20; 15(6):1978-80. PubMed ID: 3382244
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical study on the effect of intratumoral administration of OK-432 on breast cancer--anti-tumor immune response at the site of local injection].
    Hosokawa T.
    Nihon Geka Gakkai Zasshi; 1991 May 20; 92(5):577-86. PubMed ID: 1831533
    [Abstract] [Full Text] [Related]

  • 7. [Clinical efficacy of intratumoral administration of BRM in advanced cancer and their mechanism of actions].
    Kuninobu H, Toge T, Takayama T, Baba N, Kegoya Y, Yanagawa E.
    Gan To Kagaku Ryoho; 1989 Aug 20; 16(8 Pt 2):2769-73. PubMed ID: 2782888
    [Abstract] [Full Text] [Related]

  • 8. The prognostic advantage of preoperative intratumoral injection of OK-432 for gastric cancer patients.
    Gochi A, Orita K, Fuchimoto S, Tanaka N, Ogawa N.
    Br J Cancer; 2001 Feb 20; 84(4):443-51. PubMed ID: 11207036
    [Abstract] [Full Text] [Related]

  • 9. [A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)].
    Shiraishi T, Nio Y, Imai S, Tsubono M, Morimoto H, Tseng CC, Tobe T, Tanaka T, Kitamura O, Sakanashi S.
    Nihon Gan Chiryo Gakkai Shi; 1990 May 20; 25(5):997-1012. PubMed ID: 2202770
    [Abstract] [Full Text] [Related]

  • 10. [Local immunotherapy of breast cancer: a case of advanced breast cancer improved by combined local injection therapy with OK-432 and rIL-2].
    Fujimori M, Sugenoya A, Kobayashi S, Masuda H, Komatsu M, Takahashi S, Shimizu T, Tsuchiya S, Iida F.
    Gan To Kagaku Ryoho; 1989 Aug 20; 16(8 Pt 2):2760-3. PubMed ID: 2551219
    [Abstract] [Full Text] [Related]

  • 11. [Clinical investigation of intratumoral OK-432 administration].
    Shimada K, Tabuse K, Kono N, Katsumi M, Yamamoto H, Yamamoto Y, Endo A.
    Gan To Kagaku Ryoho; 1983 Aug 20; 10(8):1844-9. PubMed ID: 6882008
    [Abstract] [Full Text] [Related]

  • 12. [Hemodynamic effects of a large dose injection of OK-432 (picibanil)].
    Morita K, Murata T, Marumoto M, Tsuboi H, Nakahara Y, Oda T, Mohri H.
    Nihon Geka Gakkai Zasshi; 1983 Apr 20; 84(4):295-300. PubMed ID: 6674797
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Effect of combined use of radiation and twice intratumor administration of OK-432 at one week intervals against a murine fibrosarcoma (NFSA)].
    Mukai M, Ando K, Koike S.
    Gan To Kagaku Ryoho; 1988 Apr 20; 15(4 Pt 1):631-5. PubMed ID: 3355184
    [Abstract] [Full Text] [Related]

  • 16. [Immunotherapy of non-resectable or recurrent cancer with a streptococcal preparation, OK-432--changes in immunologic parameters and evaluation of the periods of survival following intradermal and intramuscular injections].
    Hanaue H, Nomoto S, Seto A, Kimura T, Kutsuna T, Takeuchi T, Yoshizaki S.
    Nihon Gan Chiryo Gakkai Shi; 1982 Dec 20; 17(8):1975-85. PubMed ID: 7169568
    [No Abstract] [Full Text] [Related]

  • 17. [Endoscopic preoperative intralesional injection of OK-432 in early gastric cancer].
    Yamane T, Sagara Y, Suzuki G, Kasuga M, Sakita M, Fujita Y, Majima S.
    Gan To Kagaku Ryoho; 1984 Apr 20; 11(4):930-4. PubMed ID: 6721507
    [Abstract] [Full Text] [Related]

  • 18. Anti-tumor effects of the oral administration of the streptococcal preparation OK-432 (PICIBANIL)--the inhibition of carcinogenesis and growth in rats with ENNG-induced gastrointestinal tumors.
    Takeshita M, Makita F, Takeyoshi I, Ishikawa H, Nakamura S, Owada S, Miyamoto Y, Izuo M, Kurashige S.
    Jpn J Surg; 1990 May 20; 20(3):316-26. PubMed ID: 2359208
    [Abstract] [Full Text] [Related]

  • 19. [A case of recurrence of gastric cancer with an abdominal wall tumor responding to intratumoral OK-432 administration].
    Saeki T, Kuninobu H, Niimoto M, Hattori T, Ohoya M, Yoshida H, Sata H, Kajitani Y.
    Gan No Rinsho; 1987 Apr 20; 33(4):417-20. PubMed ID: 2952818
    [Abstract] [Full Text] [Related]

  • 20. Intratumoral administration of streptococcal preparation (OK-432) to advanced pancreatic cancer.
    Kodama M, Tanaka T.
    Hiroshima J Med Sci; 1983 Jun 20; 32(2):167-71. PubMed ID: 6618899
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.